Background: Infliximab-induced seizures in patients with Crohn’s disease are extremely rare and the mechanism of infliximab-induced seizures is unclear. Case presentation: A 60-year-old woman with Crohn’s disease experienced infliximab-induced seizures, diagnosed on normal magnetic resonance imaging of the brain. Moreover, the rechallenge with infliximab was positive. Conclusions: Neurological assessment and tight clinical monitoring before and during therapy with infliximab should be performed in patients with pre-existing seizure disorders.
CITATION STYLE
Lv, Z., Zhang, X., & Wu, L. (2021). Infliximab‐induced seizures in a patient with Crohn’s disease: a case report. BMC Gastroenterology, 21(1). https://doi.org/10.1186/s12876-021-01780-y
Mendeley helps you to discover research relevant for your work.